AIM ImmunoTech (AIM) Institutional Ownership $0.12 -0.01 (-11.04%) Closing price 04:00 PM EasternExtended Trading$0.12 +0.00 (+0.75%) As of 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for AIM ImmunoTech (NYSE:AIM)CurrentInstitutional OwnershipPercentage12.02%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$1.52MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$19.56K Get AIM Insider Trade Alerts Want to know when executives and insiders are buying or selling AIM ImmunoTech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AIM Institutional Buying and Selling by Quarter AIM ImmunoTech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Citadel Advisors LLC358,987$71K0.0%-21.6%0.563% 8/15/2024 Armistice Capital LLC4,078,000$1.52M0.0%N/A7.919% 11/16/2021 Verition Fund Management LLC148,479$300K0.0%+37.5%0.310% 11/15/2021 HighTower Advisors LLC41,095$82K0.0%-38.8%0.086% 10/28/2021 WINTON GROUP Ltd82,564$167K0.0%+50.4%0.173% 10/19/2021 Arkadios Wealth Advisors21,597$43K0.0%N/A0.045% 8/17/2021 Bridgeway Capital Management LLC246,000$529K0.0%-9.2%0.514% 8/16/2021 Schonfeld Strategic Advisors LLC23,100$49K0.0%-40.0%0.048% 8/16/2021 State Street Corp160,413$345K0.0%N/A0.335% 8/13/2021 Renaissance Technologies LLC152,848$329K0.0%-68.1%0.320% Get the Latest News and Ratings for AIM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AIM ImmunoTech and its competitors with MarketBeat's FREE daily newsletter. 8/13/2021 Northern Trust Corp87,226$188K0.0%+28.8%0.182% 8/13/2021 Vanguard Group Inc.1,993,156$4.29M0.0%+3.5%4.167% 8/12/2021 XTX Topco Ltd29,269$63K0.0%N/A0.061% 8/12/2021 Dimensional Fund Advisors LP139,160$299K0.0%N/A0.291% 8/10/2021 WINTON GROUP Ltd54,894$118K0.0%N/A0.115% 6/4/2021Lehman & Derafelo Financial Resources LLC11,100$25K0.0%N/A0.023% 5/19/2021 Virtu Financial LLC29,484$67K0.0%-71.6%0.062% 5/18/2021 Verition Fund Management LLC108,000$245K0.0%+80.0%0.226% 5/18/2021 Morgan Stanley2,505,954$5.69M0.0%+150.9%5.240% 5/18/2021 Citadel Advisors LLC103,283$234K0.0%N/A0.216% 5/17/2021 Schonfeld Strategic Advisors LLC38,500$88K0.0%N/A0.081% 5/13/2021 Renaissance Technologies LLC478,759$1.09M0.0%N/A1.001% 5/12/2021 Geode Capital Management LLC351,750$798K0.0%+49.7%0.736% 5/11/2021 Rockefeller Capital Management L.P.40,000$90K0.0%+100.0%0.084% 5/10/2021 HighTower Advisors LLC63,095$143K0.0%N/A0.132% 5/10/2021 GSA Capital Partners LLP74,790$170K0.0%+338.7%0.156% 5/7/2021BlackRock Inc.979,042$2.22M0.0%+91.7%2.047% 5/7/2021 Cambridge Investment Research Advisors Inc.46,679$106K0.0%+14.7%0.098% 5/4/2021 Community Bank N.A.13,226$30K0.0%N/A0.028% 4/21/2021Lehman & Derafelo Financial Resources LLC11,100$25K0.0%N/A0.023% 2/24/2021 Virtu Financial LLC103,807$186K0.0%+250.7%0.255% 2/18/2021 Verition Fund Management LLC60,000$107K0.0%+50.0%0.147% 2/5/2021BlackRock Inc.510,796$914K0.0%+1.6%1.255% 2/4/2021 Cambridge Investment Research Advisors Inc.40,679$73K0.0%+19.0%0.100% (Data available from 1/1/2016 forward) AIM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AIM shares? During the previous two years, the following institutional investors and hedge funds held shares of AIM ImmunoTech shares: Armistice Capital LLC ($1.52M), Citadel Advisors LLC ($71K).Learn more on AIM's institutional investors. What percentage of AIM ImmunoTech stock is owned by institutional investors? 12.02% of AIM ImmunoTech stock is owned by institutional investors. Learn more on AIM's institutional investor holdings. Which institutional investors have been buying AIM ImmunoTech stock? The following institutional investors have purchased AIM ImmunoTech stock in the last 24 months: Armistice Capital LLC ($4.08M). How much institutional buying is happening at AIM ImmunoTech? Institutional investors have bought a total of 4,078,000 shares in the last 24 months. This purchase volume represents approximately $1.52M in transactions. Which AIM ImmunoTech major shareholders have been selling company stock? The following institutional investors have sold AIM ImmunoTech stock in the last 24 months: Citadel Advisors LLC ($98.78K). How much institutional selling is happening at AIM ImmunoTech? Institutional investors have sold a total of 98,780 shares in the last 24 months. This volume of shares sold represents approximately $19.56K in transactions. Related Companies OSTX Major Shareholders SRZN Major Shareholders CVKD Major Shareholders CLNN Major Shareholders ELEV Major Shareholders IBIO Major Shareholders SNYR Major Shareholders PLUR Major Shareholders PASG Major Shareholders VRCA Major Shareholders This page (NYSE:AIM) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIM ImmunoTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIM ImmunoTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
